A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren’s Syndrome May 19, 2020https://www.clinicaltrials.gov/ct2/show/NCT04035668 A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren’s Syndrome (LOUiSSe)
Potential Sjogren’s Therapy LOU064 Shows Promise in Early Lab Studies, Healthy Volunteers January 16, 2020Potential Sjogren’s Therapy LOU064 Shows Promise in Early Lab Studies, Healthy Volunteers Potential Sjogren’s Therapy LOU064 Shows Promise in Early Lab Studies, Healthy Volunteers